106 related articles for article (PubMed ID: 34673212)
1. Meta-analysis for association of TNFA-308(G > A) SNP with vitiligo susceptibility.
Giri PS; Begum R; Dwivedi M
Gene; 2022 Jan; 809():146027. PubMed ID: 34673212
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor (TNF)-α- 308 G/A gene polymorphism (rs1800629) in Egyptian patients with alopecia areata and vitiligo, a laboratory and in silico analysis.
Abd El-Raheem T; Mahmoud RH; Hefzy EM; Masoud M; Ismail R; Aboraia NMM
PLoS One; 2020; 15(12):e0240221. PubMed ID: 33370782
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with vitiligo.
Al-Harthi F; Zouman A; Arfin M; Tariq M; Al-Asmari A
Genet Mol Res; 2013 Jul; 12(3):2196-204. PubMed ID: 23884763
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of the TNF-α-308G/A polymorphism and vitiligo risk.
Nie G; Qi JH; Huang CW; Yang T; Shi N; Chen YJ
Genet Mol Res; 2015 Dec; 14(4):17296-304. PubMed ID: 26681224
[TBL] [Abstract][Full Text] [Related]
5. Associations between TNF-α polymorphisms and susceptibility to rheumatoid arthritis and vitiligo: a meta-analysis.
Lee YH; Bae SC
Genet Mol Res; 2015 May; 14(2):5548-59. PubMed ID: 26125752
[TBL] [Abstract][Full Text] [Related]
6. The association between tumor necrosis factor-α-308 G/A polymorphism and risk for vitiligo: a meta-analysis.
Wu D; Shi D; Zhu X
Int J Dermatol; 2015 Sep; 54(9):1045-53. PubMed ID: 26224639
[TBL] [Abstract][Full Text] [Related]
7. Identification of TNF-α as Major Susceptible Risk Locus for Vitiligo: A Systematic Review and Meta-Analysis Study in the Asian Population.
Dutta T; Sengupta S; Adhya S; Saha A; Sengupta D; Mondal R; Naskar S; Bhattacharjee S; Sengupta M
Dermatology; 2024; 240(3):376-386. PubMed ID: 38377977
[TBL] [Abstract][Full Text] [Related]
8. Lack of association with TNF-alpha-308 promoter polymorphism in patients with vitiligo.
Yazici AC; Erdal ME; Kaya TI; Ikizoglu G; Savasoglu K; Camdeviren H; Tursen U
Arch Dermatol Res; 2006 Jun; 298(1):46-9. PubMed ID: 16691430
[TBL] [Abstract][Full Text] [Related]
9. Association Analysis of Tumor Necrosis Factor Alpha Promoter Polymorphisms and Vitiligo Susceptibility in South Indian Tamils.
Rajendiran KS; Rajappa M; Chandrashekar L; Thappa DM; Devaraju P
Dermatology; 2020; 236(6):554-564. PubMed ID: 32074604
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of TNF-α promoter -308A/G polymorphism and SLE susceptibility in Asian populations.
Zou YF; Feng XL; Tao JH; Su H; Pan FM; Liao FF; Fan Y; Ye DQ
Rheumatol Int; 2011 Aug; 31(8):1055-64. PubMed ID: 20333386
[TBL] [Abstract][Full Text] [Related]
11. The Synergistic Effect of TNFA and IL10 Promoter Polymorphisms on Genetic Predisposition to Systemic Lupus Erythematosus.
Manolova I; Miteva L; Ivanova M; Kundurzhiev T; Stoilov R; Stanilova S
Genet Test Mol Biomarkers; 2018 Feb; 22(2):135-140. PubMed ID: 29298134
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of tumor necrosis factor-alpha and breast cancer risk: a meta-analysis.
Shen C; Sun H; Sun D; Xu L; Zhang X; Liu A; Jia X; Bai J; Chen F; Yu Y; Jin Y; Yu J; Fu S
Breast Cancer Res Treat; 2011 Apr; 126(3):763-70. PubMed ID: 20882404
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha rs1800629 polymorphism and risk of cervical lesions: a meta-analysis.
Li M; Han Y; Wu TT; Feng Y; Wang HB
PLoS One; 2013; 8(8):e69201. PubMed ID: 24015171
[TBL] [Abstract][Full Text] [Related]
14. Biological and Clinical Implications of TNF-α Promoter and CYP1B1 Gene Variations in Coronary Artery Disease Susceptibility.
Mir R; Elfaki I; Jha CK; Javid J; Babakr AT; Banu S; Mir MM; Jamwal D; Khullar N; Alzahrani KJ; Chahal SMS
Cardiovasc Hematol Disord Drug Targets; 2021; 21(4):266-277. PubMed ID: 34939556
[TBL] [Abstract][Full Text] [Related]
15. Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo.
Laddha NC; Dwivedi M; Begum R
PLoS One; 2012 Dec; 7(12):e52298. PubMed ID: 23284977
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis identified the TNFA -308G > A promoter polymorphism as a risk factor for disease severity in patients with rheumatoid arthritis.
Toonen EJ; Barrera P; Fransen J; de Brouwer AP; Eijsbouts AM; Miossec P; Marotte H; Scheffer H; van Riel PL; Franke B; Coenen MJ
Arthritis Res Ther; 2012 Dec; 14(6):R264. PubMed ID: 23217265
[TBL] [Abstract][Full Text] [Related]
17. Association of interferon-gamma and tumor necrosis factor alpha polymorphisms with susceptibility to vitiligo in Iranian patients.
Namian AM; Shahbaz S; Salmanpoor R; Namazi MR; Dehghani F; Kamali-Sarvestani E
Arch Dermatol Res; 2009 Jan; 301(1):21-5. PubMed ID: 18820938
[TBL] [Abstract][Full Text] [Related]
18. Impact of
Areeshi MY; Mandal RK; Dar SA; Jawed A; Wahid M; Lohani M; Panda AK; Mishra BN; Akhter N; Haque S
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28935761
[TBL] [Abstract][Full Text] [Related]
19. Association analysis of single nucleotide polymorphisms of proinflammatory cytokine and their receptors genes with rheumatoid arthritis in northwest Chinese Han population.
You CG; Li XJ; Li YM; Wang LP; Li FF; Guo XL; Gao LN
Cytokine; 2013 Jan; 61(1):133-8. PubMed ID: 23148991
[TBL] [Abstract][Full Text] [Related]
20. Significant association of TNF-α, but not other pro-inflammatory cytokines, single nucleotide polymorphisms with intervertebral disc degeneration in Iranian population.
Abdollahzade S; Hanaei S; Sadr M; Mirbolouk MH; Fattahi E; Rezaei N; Khoshnevisan A
Clin Neurol Neurosurg; 2018 Oct; 173():77-83. PubMed ID: 30092407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
